News
May 2, 2023
IGM Biosciences to Present at Two Upcoming Investor Conferences
Additional Formats
April 19, 2023
IGM Biosciences to Present at the Stifel 2023 Targeted Oncology Days
Additional Formats
April 13, 2023
IGM Biosciences Announces Six Presentations at the American Association for Cancer Research Annual Meeting 2023
Additional Formats
March 30, 2023
IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Additional Formats
March 27, 2023
IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023
Additional Formats
February 2, 2023
IGM Biosciences to Present at the Guggenheim 2023 Oncology Conference
Additional Formats
January 17, 2023
IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-7354 in Solid Tumors
Additional Formats
January 9, 2023
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
Additional Formats
January 3, 2023
IGM Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
Additional Formats
Displaying 11 - 19 of 19